Abstract
Streptococcus suis is an economically important pathogen of pigs as well as a zoonotic cause of human disease. Serotyping is used for further characterization of isolates; some serotypes seem to be more virulent and more widely spread than others. This study characterizes a collection of German field isolates of Streptococcus suis from pigs dating from 1996 to 2016 with respect to capsular genes (cps) specific for individual serotypes and pathotype by multiplex PCR and relates results to the clinical background of these isolates. The most prominent finding was the reduction in prevalence of serotype-2/serotype-1/2 among invasive isolates during this sampling period, which might be attributed to widely implemented autogenous vaccination programs in swine against serotype 2 in Germany. In diseased pigs (systemically ill; respiratory disease) isolates of serotype-1/serotype-14, serotype-2/serotype-1/2, serotype 3 to 5 and 7 to 9 were most frequent while in carrier isolates a greater variety of cps types was found. Serotype-1/serotype-14 seemed to be preferentially located in joints, serotype 4 and serotype 3 in the central nervous system, respectively. The virulence associated extracellular protein factor was almost exclusively associated with invasive serotype-1/serotype-14 and serotype-2/serotype-1/2 isolates. In contrast, lung isolates of serotype-2/serotype-1/2 mainly harbored the gene for muramidase-released protein. Serotype 4 and serotype 9 isolates from clinically diseased pigs most frequently carried the muramidase-released protein gene and the suilysin gene. When examined by transmission electron microscopy all but one of the isolates which were non-typable by molecular and serological methods showed various amounts of capsular material indicating potentially new serotypes among these isolates. Given the variety of cps types/serotypes detected in pigs, not only veterinarians but also medical doctors should consider other serotypes than just serotype 2 when investigating potential human cases of Streptococcus suis infection.
Highlights
Streptococcus (S.) suis is a facultative pathogen affecting humans, feral and domestic pigs
In all 711 isolates from collection A (1996–2004) and B (2015–2016) investigated in this study, including all non-cps-typable isolates, gdh and recN could be detected by the two PCR assays implemented
From several published PCR assays designed for detecting important [11], many, or all serotypes of S. suis [5, 21, 22], we selected the method described by Okura et al in 2014 [5] to Molecular typing of Streptococcus suis examine two collections of S. suis isolates from pigs in Germany which were compiled approximately 10 years apart
Summary
Streptococcus (S.) suis is a facultative pathogen affecting humans, feral and domestic pigs. In Asia, where humans and pigs often live in close proximity, zoonotic epidemics with large numbers of human cases and even fatalities have been recorded in 1998 and 2005 [1]. S. suis is the most common cause of adult meningitis in Vietnam [2]. In Western countries infections in humans usually occur only sporadically in those persons professionally occupied with keeping, handling or slaughtering pigs or processing their meat [1]. Asymptomatic colonization of the upper respiratory tract with S. suis, and of the intestinal and genital tract, is common. S. suis is one of the economically most important pathogens in the pig industry causing primarily meningitis, arthritis and septicemia mainly in piglets and weaners [3, 4]
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.